PATENT CLAIM ANALYSIS

Application Number: 15881493
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "139100"]

Abstract:
The present disclosure provides binding proteins, such as antibodies, that bind glucagon receptors, including a human glucagon receptor, and methods of their use.

Claim (Index 73):
The antibody of  claim 66 , which:\n (a) inhibits GCGR signaling in cells expressing GCGR; (b) inhibits GCGR activity in a cell; (c) inhibits GCGR activity in a cell wherein the GCGR activity is induced by glucagon; and/or (d) inhibits cAMP activity.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 86.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13113996', '11903481', '14268933', '15228254', '13625417']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.731045941964498
- 35 USC 102 Novelty (BERT): 0.5434839850333002
- Combined Prediction Score: 0.7122897462713783
- Mean Citation Score: 362.08624
- Max Citation Score: 379.02307
- Similarity Product: 244.9449729112017

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test